Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
991 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00605267 | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | completed | Phase 3 | 197 | AstraZenecaINDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00264004 | Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours | completed | Phase 2 | 119 | AstraZenecaINDUSTRY | 3 | Aug 29, 2012 | clinicaltrials |
| NCT00259090 | Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer | completed | Phase 2 | 120 | AstraZenecaINDUSTRY | 1 | Aug 16, 2012 | clinicaltrials |
| NCT00929162 | ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer | terminated | Phase 2 | 120 | AstraZenecaINDUSTRY | 2 | Aug 7, 2012 | clinicaltrials |
| NCT00256698 | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy(FACT) | completed | Phase 3 | 514 | AstraZenecaINDUSTRY | 12 | Aug 1, 2012 | clinicaltrials |
| NCT00334295 | Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. | completed | Phase 2 | 35 | AstraZenecaINDUSTRY | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00385203 | The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). | completed | Phase 2 | 35 | AstraZenecaINDUSTRY | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00731263 | A Study of Tor Kinase Inhibitor in Advanced Tumors | completed | Phase 1 | 64 | AstraZenecaINDUSTRY | 3 | Jul 11, 2012 | clinicaltrials |
| NCT00999882 | Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients | completed | Phase 1 | 26 | AstraZenecaINDUSTRY | 2 | Jul 10, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00254579 | Study of CP-675,206 in Refractory Melanoma | completed | Phase 2 | 251 | AstraZenecaINDUSTRY | 9 | Jun 7, 2012 | clinicaltrials |
| NCT00312975 | Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | AstraZenecaINDUSTRY | 5 | Jun 7, 2012 | clinicaltrials |
| NCT00313794 | Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment | completed | Phase 2 | 49 | AstraZenecaINDUSTRY | 2 | Jun 7, 2012 | clinicaltrials |
| NCT00075192 | CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer | completed | Phase 1 / Phase 2 | 8 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00086489 | CP-675,206 In Patients With Advanced Melanoma | completed | Phase 2 | 118 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00372853 | Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma | completed | Phase 1 | 28 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00431275 | Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody | completed | Phase 1 | 85 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00478049 | Iressa as Second Line Therapy in Advanced NSCLC-Asia(ISTANA) | completed | Phase 3 | 163 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00556023 | A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer | completed | Phase 1 | 37 | AstraZenecaINDUSTRY | 2 | Jun 6, 2012 | clinicaltrials |
| NCT00585000 | A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma | terminated | Phase 1 | 49 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00657904 | Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer | completed | Phase 3 | 3,618 | AstraZenecaINDUSTRY | 2 | Jun 6, 2012 | clinicaltrials |
| NCT00660244 | Breast Cancer Tumor Care Observational Programme | completed | — | 150 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00692289 | Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer(RADAR II E) | completed | — | 1,510 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00745875 | ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 5 | Jun 6, 2012 | clinicaltrials |
| NCT00787410 | An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma | completed | Phase 2 | 23 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT00849030 | ATAC - Arimidex, Tamoxifen Alone or in Combination | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT01247168 | An Open-Label, Dose-Escalation Study of AZD2461 | completed | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00323479 | Arthralgia During Anastrozole Therapy for Breast Cancer | completed | Phase 4 | 114 | AstraZenecaINDUSTRY | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00305448 | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg(FINDER I) | completed | Phase 2 | 143 | AstraZenecaINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00936442 | Arimidex Therapy Compliance Electronic Monitoring System(ARTEMIS) | completed | — | 104 | AstraZenecaINDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00555867 | Patient's Anastrozole Compliance to Therapy Programme(PACT) | terminated | — | 4,923 | AstraZenecaINDUSTRY | 0 | Dec 23, 2011 | clinicaltrials |
| NCT00880711 | Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)(FIONA) | completed | — | 57 | AstraZenecaINDUSTRY | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00769080 | The Performance of Patient Support Program in Early Stage Breast Cancer(ARI NIS) | completed | — | 524 | AstraZenecaINDUSTRY | 1 | Nov 29, 2011 | clinicaltrials |
| NCT01265654 | Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer(HOT ABC) | completed | — | 234 | AstraZenecaINDUSTRY | 1 | Nov 23, 2011 | clinicaltrials |
| NCT01081509 | Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence(ARIADNE) | completed | — | 1,077 | AstraZenecaINDUSTRY | 1 | Nov 16, 2011 | clinicaltrials |
| NCT01103089 | Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) | completed | — | 10 | AstraZenecaINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00944918 | Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) | completed | Phase 3 | 25 | AstraZenecaINDUSTRY | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00454090 | AZD8330 First Time in Man in Patients With Advanced Malignancies | completed | Phase 1 | 83 | AstraZenecaINDUSTRY | 2 | Aug 24, 2011 | clinicaltrials |
| NCT01185314 | To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)(PIONEER) | completed | N/A | 1,270 | AstraZenecaINDUSTRY | 7 | Aug 8, 2011 | clinicaltrials |
| NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | completed | Phase 1 | 104 | AstraZenecaINDUSTRY | 1 | Jul 27, 2011 | clinicaltrials |
| NCT00748891 | DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) | completed | Phase 1 | 35 | AstraZenecaINDUSTRY | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00737009 | An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment | completed | — | 259 | AstraZenecaINDUSTRY | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00981721 | A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 1 | Jun 20, 2011 | clinicaltrials |
| NCT00926731 | Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC) | completed | Phase 1 | 4 | AstraZenecaINDUSTRY | 2 | Jun 16, 2011 | clinicaltrials |
| NCT00973076 | Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00960349 | Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients | completed | Phase 1 | 14 | AstraZenecaINDUSTRY | 1 | Jun 14, 2011 | clinicaltrials |
| NCT00539331 | Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients | terminated | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 1, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials